Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01323673 · ClinicalTrials.gov registry record · Phase 4
Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.
A Phase 4 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 125
- Enrollment target
NCT01323673 is a Phase 4 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 125 participants.
The verdict
NCT01323673, a Phase 4 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 125 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how clobetasol proprionate foam works against a placebo foam in the treatment of hand dermatitis.
Interventions
- DRUG clobetasol propionate 0.05%
- DRUG Vehicle / Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2010-11-15 |
| Est. Completion | 2011-03-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01323673
The ClinicalTrials.gov registry entry for NCT01323673 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stiefel, a GSK Company, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which clobetasol propionate 0.05% is the first listed.
NCT01323673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01323673 about?
NCT01323673 is a clinical study titled "Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.". The purpose of this study is to determine how clobetasol proprionate foam works against a placebo foam in the treatment of hand dermatitis.
What is the current status of trial NCT01323673?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 125 participants. The study started on 2010-11-15. Estimated completion is 2011-03-29.
What interventions are being tested in trial NCT01323673?
The interventions under investigation include: clobetasol propionate 0.05% (DRUG), Vehicle / Placebo (DRUG).
Who is sponsoring clinical trial NCT01323673?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.